These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 29843069

  • 1. Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers.
    Wang M, Liang L, Lei X, Multani A, Meric-Bernstam F, Tripathy D, Wu Y, Chen H, Zhang H.
    Ann Diagn Pathol; 2018 Aug; 35():69-76. PubMed ID: 29843069
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].
    Zeng X, Liang ZY, Wu SF, Zhou WX, Gao J, Liu TH.
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):584-8. PubMed ID: 17134563
    [Abstract] [Full Text] [Related]

  • 3. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Catenacci DV, Ang A, Liao WL, Shen J, O'Day E, Loberg RD, Cecchi F, Hembrough T, Ruzzo A, Graziano F.
    Cancer; 2017 May 15; 123(6):1061-1070. PubMed ID: 27926778
    [Abstract] [Full Text] [Related]

  • 4. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M, Amir M, Hassan MJ, Hussain MS, Aziz MN, Murad S, Murtaza I, Anees M, Sultan A.
    Tumour Biol; 2016 Jul 15; 37(7):8665-72. PubMed ID: 26738861
    [Abstract] [Full Text] [Related]

  • 5. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.
    Kuo SJ, Wang BB, Chang CS, Chen TH, Yeh KT, Lee DJ, Yin PL, Chen M.
    Taiwan J Obstet Gynecol; 2007 Jun 15; 46(2):146-51. PubMed ID: 17638622
    [Abstract] [Full Text] [Related]

  • 6. [Analysis of HER2 status in breast carcinoma using fully automated HER2 staining and fluorescence in-situ hybridization technology].
    Ying JM, Liu XY, Guo L, Xie YQ, Lü N.
    Zhonghua Bing Li Xue Za Zhi; 2012 May 15; 41(5):296-300. PubMed ID: 22883666
    [Abstract] [Full Text] [Related]

  • 7. Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.
    Preusser M, Streubel B, Berghoff AS, Hainfellner JA, von Deimling A, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, Zielinski C, Birner P.
    Histopathology; 2014 Nov 15; 65(5):684-92. PubMed ID: 25039982
    [Abstract] [Full Text] [Related]

  • 8. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ, Seo AN, Park SY, Kim JY, Park JY, Yu JH, Ahn JH, Gong G.
    Ann Surg Oncol; 2014 May 15; 21(5):1561-8. PubMed ID: 24385208
    [Abstract] [Full Text] [Related]

  • 9. High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients.
    Park S, Choi YL, Sung CO, An J, Seo J, Ahn MJ, Ahn JS, Park K, Shin YK, Erkin OC, Song K, Kim J, Shim YM, Han J.
    Histol Histopathol; 2012 Feb 15; 27(2):197-207. PubMed ID: 22207554
    [Abstract] [Full Text] [Related]

  • 10. c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.
    Mignard X, Ruppert AM, Antoine M, Vasseur J, Girard N, Mazières J, Moro-Sibilot D, Fallet V, Rabbe N, Thivolet-Bejui F, Rouquette I, Lantuejoul S, Cortot A, Saffroy R, Cadranel J, Lemoine A, Wislez M.
    J Thorac Oncol; 2018 Dec 15; 13(12):1962-1967. PubMed ID: 30149144
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD, Vanner EA, Romeiser JL, Shroyer ALW, Escobar-Hoyos LF, Li J, Powers RS, Burke S, Shroyer KR.
    Hum Pathol; 2017 Apr 15; 62():23-32. PubMed ID: 27816721
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
    Ciampa A, Xu B, Ayata G, Baiyee D, Wallace J, Wertheimer M, Edmiston K, Khan A.
    Appl Immunohistochem Mol Morphol; 2006 Jun 15; 14(2):132-7. PubMed ID: 16785779
    [Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E, Villanacci V, Danesino C, Donato F, Nascimbeni R, Bassotti G.
    Rev Esp Enferm Dig; 2011 Dec 15; 103(12):632-9. PubMed ID: 22217347
    [Abstract] [Full Text] [Related]

  • 16. MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer.
    Yin W, Cheng J, Tang Z, Toruner G, Hu S, Guo M, Robinson M, Medeiros LJ, Tang G.
    Clin Lung Cancer; 2021 Jul 15; 22(4):e512-e518. PubMed ID: 33288441
    [Abstract] [Full Text] [Related]

  • 17. Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.
    Nakajima H, Ishikawa Y, Furuya M, Sano T, Ohno Y, Horiguchi J, Oyama T.
    Breast Cancer; 2014 Jan 15; 21(1):66-74. PubMed ID: 22481575
    [Abstract] [Full Text] [Related]

  • 18. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma.
    Couturier J, Vincent-Salomon A, Nicolas A, Beuzeboc P, Mouret E, Zafrani B, Sastre-Garau X.
    Mod Pathol; 2000 Nov 15; 13(11):1238-43. PubMed ID: 11106082
    [Abstract] [Full Text] [Related]

  • 19. [HER-2 overexpression and gene amplification of advanced breast cancers determined by fluorescence in situ hybridization in fine needle aspiration specimens].
    Zhang Z, Zhao L, Guo H, Guo L, Ling Y, Xu X, Zhao H, Pan Q.
    Zhonghua Zhong Liu Za Zhi; 2014 Mar 15; 36(3):183-7. PubMed ID: 24785277
    [Abstract] [Full Text] [Related]

  • 20. MET amplification, protein expression, and mutations in pulmonary adenocarcinoma.
    Park S, Koh J, Kim DW, Kim M, Keam B, Kim TM, Jeon YK, Chung DH, Heo DS.
    Lung Cancer; 2015 Dec 15; 90(3):381-7. PubMed ID: 26791796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.